天天中文日韩熟妇天堂,国产色精品视频91色,亚洲伊人久久在线,亚洲熟女五十路,亚洲人妻丝袜在线,亚洲综合日韩在线,亚洲欧美另类熟女精品,大量国产欧美日韩久久,日韩 欧美亚洲

3358288340
CN
CN EN
Human Granulocyte Colony-stimulating Factor Injection
Since its introduction into the market in 1999, WHITE-C has been clinically applied for more than 20 years, with a wide range of evidence-based applications, topping the list of domestic similar products in terms of export volume. As strict in-house control quality standards are followed, WHITE-C is not only in line with Chinese Pharmacopoeia, but also European Pharmacopoeia.
Drug description

【Indications】

①Neutropenia due to cancer chemotherapy and other reasons;

②Neutropenia due to chemotherapy for acute leukemia.


【R&D and Commercial Production of WHITE-C】

In 1990, an efficiently and stably expressed G-CSF engineered cell line was constructed;


In 1992, preclinical pilot-scale production processes and preclinical animal trials were successfully completed;


In 1994, clinical trial application was submitted;


In 1998, the phase I/II clinical trial approved by the Bureau of Drug Policy & Administration of Ministry of Health was completed;


In 1999, the new drug certificate issued by the Ministry of Health was obtained;


In 2000, trial production was conducted and various tests by the National Institutes for Food and Drug Control were passed;


In 2001, the approval for formal production was obtained;


In 2009, supplementary approval was obtained for the prefilled syringe;


In 2017, pegylated human granulocyte colony-stimulating factor for injection was approved for research and development.

Drug description
咸丰县| 阳谷县| 定远县| 衡东县| 上饶市| 陵川县| 新竹市| 城市| 清镇市| 宁海县| 北京市| 澄江县| 山阳县| 高邮市| 米脂县| 乐安县| 海口市| 五家渠市| 闽清县| 息烽县| 桑日县| 德钦县| 贡嘎县| 来宾市| 沙雅县| 嵩明县| 崇信县| 红河县| 贵州省| 博爱县| 玉山县| 彰武县| 深泽县| 乐山市| 牡丹江市| 贵定县| 饶平县| 同仁县| 抚宁县| 包头市| 临湘市|